AG00HRMS

127-69-5 | 4-​Amino-​N-​(3,​4-​dimethyl-​5-​isoxazolyl)​benzenesulfonamide

AG00HRMS

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	127-69-5
Catalog Number	AG00HRMS(AGN-PC-0JK77N)
Chemical Name	4-​Amino-​N-​(3,​4-​dimethyl-​5-​isoxazolyl)​benzenesulfonamide
EC Number	204-858-9
IUPAC Name	4-amino-N-(3,4-dimethyl-1,2-oxazol-5-yl)benzenesulfonamide
InChI	InChI=1S/C11H13N3O3S/c1-7-8(2)13-17-11(7)14-18(15,16)10-5-3-9(12)4-6-10/h3-6,14H,12H2,1-2H3
InChI Key	NHUHCSRWZMLRLA-UHFFFAOYSA-N
MDL Number	MFCD00003150
Molecular Formula	C11H13N3O3S
Molecular Weight	267.3042
SMILES	NC1=CC=C(C=C1)S(=O)(=O)NC1=C(C(=NO1)C)C
UNII	740T4C525W
Synonyms	Ammonium Salt Sulfisoxazole, Diolamine, Sulfisoxazole, Gantrisin, Gantrisin Pediatric, Monolithium Salt Sulfisoxazole, Monosodium Salt Sulfisoxazole, Neoxazoi, Pediatric, Gantrisin, Sulfadimethyloxazole, Sulfafurazol FNA, Sulfafurazole, Sulfasoxizole, Sulfisoxazole, Sulfisoxazole Diolamine, Sulfisoxazole, Ammonium Salt, Sulfisoxazole, Monolithium Salt, Sulfisoxazole, Monosodium Salt, Sulfisoxazole, Monosodium, Monomesylate Salt, Sulfisoxazole, Triammonium Salt, TL azole, TL-azole, Triammonium Salt Sulfisoxazole, V Sul, V-Sul, sulfisoxazole, Sulfafurazole, 127-69-5, Sulphafurazole, Sulfisoxazol, Sulfafurazol, Sulfaisoxazole, Sulfofurazole, Sulfisoxasole, Sulphaisoxazole, Sulfadimethylisoxazole, Gantrisin, Alphazole, Amidoxal, Sulfalar, Sulfoxol, Sulfisoxazole dialamine, Sulphafurazolum, Renosulfan, Sulfasoxazole, Sulfisonazole, Accuzole, Soxomide, Sulfazin, Sulfizin, Sulsoxin, Sosol, Roxosul tablets, Sulphafurazol, Sulphisoxazol, Sulphofurazole, Chemouag, Cosoxazole, Gantrisona, Gantrosan, Isoxamin, Neazolin, Neoxazol, Sulfagan, Sulfasol, Uritrisin, Entusil, Entusul, Pancid, Soxisol, Stansin, Sulbio, Thiasin, Unisulf, Norilgan-S, Tl-azole, V-Sul, SK-Soxazole, Sulfafurazolum, Sulphadimethylisoxazole, Dorsulfan, Gantrisine, Novazolo, Novosaxazole, Saxosozine, Sodizole, Soxamide, Soxazole, Soxitabs, Sulfapolar, Sulfisin, Sulfizol, Sulfizole, Urisoxin, Roxosul, Urogan, Vagilia, Azo Gantrisin, Dorsulfan warthausen, Koro-sulf, SOXO, 4-amino-N-(3,4-dimethylisoxazol-5-yl)benzenesulfonamide, Sulfisoxazolum, Sulphisoxazole, J-Sul, 3,4-Dimethyl-5-sulfonamidoisoxazole, 3,4-Dimethyl-5-sulfanilamidoisoxazole, 5-Sulfanilamido-3,4-dimethylisoxazole, Benzenesulfonamide, 4-amino-N-(3,4-dimethyl-5-isoxazolyl)-, G-sox, 4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide, Sulfazin (VAN), Azosulfizin, Sulphafuraz, 3,4-Dimethyl-5-sulphonamidoisoxazole, Astrazolo, Bactesulf, Barazae, Resoxol, Roxoxol, Sulfagen, Suloxsol, 3,4-Dimethylisoxazole-5-sulfanilamide, Ganda, 3,4-Dimethyl-5-sulphanilamidoisoxazole, 3,4-Dimethylisoxazole-5-sulphanilamide, Solfafurazolo [DCIT], 5-Sulphanilamido-3,4-dimethyl-isoxazole, NCI-C50022, Sulfafurazolum [INN-Latin], ERYZOLE, SULFISOXAZOLE DIOLAMINE, 5-(4-Aminophenylsulfonamido)-3,4-dimethylisoxazole, 5-(p-Aminobenzenesulfonamido)-3,4-dimethylisoxazole, NU 445, 5-(p-Aminobenzenesulphonamido)-3,4-dimethylisoxazole, Pediazole, N1-(3,4-Dimethyl-5-isoxazolyl)sulfanilamide, N'-(3,4)Dimethylisoxazol-5-yl-sulphanilamide, U.S.-67, 4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulphonamide, CCRIS 568, 5-Sulfanilamido-3,4-dimethyl-isoxazole, HSDB 797, Sulfafurazole (INN), N(Sup1)-(3,4-Dimethyl-5-isoxazolyl)sulfanilamide, UNII-740T4C525W, C11H13N3O3S, CHEBI:102484, Gantrisin (TN), component of Azo-Sulfizin, EINECS 204-858-9, NSC 13120, component of Azo Gantrisin, CHEMBL453, NSC 683536, BRN 0263871, N(sup 1)-(3,4-Dimethyl-5-isoxazolyl)sulphanilamide, AI3-24003, NHUHCSRWZMLRLA-UHFFFAOYSA-N, NSC13120, 3,4-Dimethylisoxale-5-sulfanilamide, MFCD00003150, N(sup 1)-(3,4-Dimethyl-5-isoxazolyl)sulfanilamide, NSC683536, Sulfafurazole [INN], 740T4C525W, Sulfisoxazole, 99%, NCGC00016384-03, NCGC00016384-10, Solfafurazolo, Sulfasoxizole, 4-amino-N-(3,4-dimethyl-1,2-oxazol-5-yl)benzenesulfonamide, 4-Amino-N-(3,4-dimethyl-isoxazol-5-yl)-benzenesulfonamide, CAS-127-69-5, Neoxazoi, DSSTox_CID_1292, N(1)-(3,4-dimethyl-5-isoxazolyl)sulfanilamide, DSSTox_RID_76064, DSSTox_GSID_21292, N(1)-(3,4-dimethyl-5-isoxazolyl)sulphanilamide, Sulfanilamide, N1-(3,4-dimethyl-5-isoxazolyl)-, 5-(p-Aminobenzenesulfonamido)-3,4-dimethylisooxale, Sulfanilamide, N(sup 1)-(3,4-dimethyl-5-isoxazolyl)-, [(4-aminophenyl)sulfonyl](3,4-dimethylisoxazol-5-yl)amine, Sulfisoxazole [USAN], Sulfafuraz ole, WLN: T5NOJ CMSWR DZ& D1 E1, Sulfanilamide,4-dimethyl-5-isoxazolyl)-, SMR000037657, Sulfafurazole(SIZ), Benzenesulfonamide,4-dimethyl-5-isoxazolyl)-, N1-(3,4-dimethylisoxazole-5-yl)sulfanilamide, SR-01000003085, Sulfisoxazole [USP:JAN], Gantrizin, US-67, Component of Azo Gantrisin Accuzole, Prestwick_726, Sulfisoxazole - Carc, 3,4-dimethylisoaxazole-5-sulfanilimide, Spectrum_001024, Tocris-0731, Prestwick0_000334, Prestwick1_000334, Prestwick2_000334, Prestwick3_000334, Spectrum2_001325, Spectrum3_001728, Spectrum4_000349, Spectrum5_001222, Azo-Sulfizin (Salt/Mix), Azo Gantrisin (Salt/Mix), Epitope ID:122240, Sulfisoxazole (JP17/USP), Sulfisoxazole, >=99.0%, Oprea1_680668, Oprea1_828173, SCHEMBL23467, BSPBio_000367, BSPBio_003376, KBioGR_000757, KBioSS_001504, 4-27-00-04747 (Beilstein Handbook Reference), MLS000028495, MLS000037737, MLS000563718, BIDD:GT0322, DivK1c_000579, SPECTRUM1500555, SPBio_001449, SPBio_002288, AC1L1K55, BPBio1_000405, DTXSID6021292, CTK7D7932, HMS501M21, KBio1_000579, KBio2_001504, KBio2_004072, KBio2_006640, KBio3_002596, Sulfafurazole;Gantrisin Pediatric, NINDS_000579, HMS1569C09, HMS2092K13, HMS2096C09, HMS2233G23, HMS3259C06, HMS3266N17, HMS3374K11, HMS3655B03, HMS3675F03, HMS3713C09, Pharmakon1600-01500555, ALBB-014131, HY-B0323, NSC33807, NSC38588, ZX-AH011786, Tox21_110409, Tox21_112958, Tox21_202265, Tox21_302851, BDBM50034452, CCG-39263, LS-713, NSC-13120, NSC-33807, NSC-38588, NSC757343, s1916, SBB007602, STK400452, ZINC96006009, AKOS000119074, AKOS000310021, Tox21_110409_1, AC-1941, CS-2364, DB00263, MCULE-3522661051, NC00536, NSC-683536, NSC-757343, ABA-9370315, IDI1_000579, NCGC00016384-01, NCGC00016384-02, NCGC00016384-04, NCGC00016384-05, NCGC00016384-06, NCGC00016384-07, NCGC00016384-08, NCGC00016384-09, NCGC00016384-11, NCGC00016384-12, NCGC00016384-14, NCGC00016384-15, NCGC00023116-02, NCGC00023116-05, NCGC00023116-06, NCGC00023116-07, NCGC00023116-08, NCGC00256605-01, NCGC00259814-01, AK114529, AN-14478, BAS 00531889, BC214921, CPD000037657, R536, SAM002554929, SC-15955, ST059445, SBI-0051529.P003, AB2000373, UPCMLD00X127-69-5:001, AB00052104, BB 0259593, FT-0631743, SW196872-3, U0098, C07318, D00450, J10241, Y-9398, AB00052104-14, AB00052104_15, AB00052104_16, Sulfisoxazole, VETRANAL(TM), analytical standard, 5-(4-Aminophenylsulphonamido)-3,4-dimethylisoxazole, J-005528, SR-01000003085-2, SR-01000003085-5, SR-01000003085-6, 5-(4-aminop henylsulfonamido)-3,4-dimethylisoxazole, 5-(p-Aminobenzenesulphonamide)-3,4-dimethylisoxazole, BRD-K50859149-001-05-4, BRD-K50859149-001-10-4, I01-15830, N(sup 1)-(3,4-dimethyl-5-isoxazolyl)-sulfanilamide, Sulfanilamide, N(sup1)-(3,4-dimethyl-5-isoxazolyl)-, Sulfanilamide, N.sup1.-(3,4-dimethyl-5-isoxazolyl)-, F0848-0391, 4-amino-N-(3,4-dimethyl-5-isoxazolyl)benzene-sulfonamide, 4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide #, 4-amino-N-(3,4-dimethylisoxazol-5-yl)-benzenesulfonamide, 4-amino-N-(dimethyl-1,2-oxazol-5-yl)benzene-1-sulfonamide, Sulfafurazole, European Pharmacopoeia (EP) Reference Standard, Sulfisoxazole, United States Pharmacopeia (USP) Reference Standard, 1021066-10-3, InChI=1/C11H13N3O3S/c1-7-8(2)13-17-11(7)14-18(15,16)10-5-3-9(12)4-6-10/h3-6,14H,12H2,1-2H, Sulphinpyrazone, Sulfasan, Mixture Name, Sulfadimethyloxazole, Sulfafurazol FNA, TL azole, Sulfisoxazole-Carc, V Sul, GANTRISIN PEDIATRIC, Pediatric, Gantrisin, Sulfafurazole diolamine, Diolamine, Sulfisoxazole, Ammonium Salt Sulfisoxazole, D09TBD, Sulfisoxazole (JP15/USP), Sulfisoxazole, Ammonium Salt, Monosodium Salt Sulfisoxazole, Sulfafurazole (Sulfisoxazole), Monolithium Salt Sulfisoxazole, Triammonium Salt Sulfisoxazole, Sulfisoxazole, Monosodium Salt, Sulfisoxazole, Monolithium Salt, Sulfisoxazole, Triammonium Salt, CID5344, C11-H13-N3-O3-S, NU-445, CS-T-42814, Sulfisoxazole, 99% - 100G 100g, B2043, Sulfisoxazole, Monosodium, Monomesylate Salt, D013444, 3,5-Pyrazolidinedione, 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]-, SI, 23256-23-7, 57-96-5,

Complexity	374
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	267.068g/mol
Formal Charge	0
Heavy Atom Count	18
Hydrogen Bond Acceptor Count	6
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	267.303g/mol
Monoisotopic Mass	267.068g/mol
Rotatable Bond Count	3
Topological Polar Surface Area	107A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	1

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H315-H319-H335
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number